Correlation Engine 2.0
Clear Search sequence regions


  • AMPK (1)
  • intestine (1)
  • liver (1)
  • LXRs (11)
  • mice (3)
  • mTOR (1)
  • nuclear receptors (1)
  • proteinuria (1)
  • rt pcr (1)
  • SIRT1 (1)
  • Sizes of these terms reflect their relevance to your search.

    Podocyte injury plays a key role in the occurrence and development of kidney diseases. Decreased autophagic activity in podocyte is closely related to its injury and the occurrence of proteinuria. Liver X receptors (LXRs), as metabolic nuclear receptors, participate in multiple pathophysiological processes and express in several tissues, including podocytes. Although the functional roles of LXRs in the liver, adipose tissue and intestine are well established; however, the effect of LXRs on podocytes function remains unclear. In this study, we used mouse podocytes cell line to investigate the effects of LXR activation on podocytes autophagy level and related signaling pathway by performing Western blotting, RT-PCR, GFP-mRFP-LC3 transfection, and immunofluorescence staining. Then, we tested this effect in STZ-induced diabetic mice. Transmission electron microscopy and immunohistochemistry were employed to explore the effects of LXR activation on podocytes function and autophagic activity. We found that LXR activation could inhibit autophagic flux through blocking the formation of autophagosome in podocytes in vitro which was possibly achieved by affecting AMPK, mTOR, and SIRT1 signaling pathways. Furthermore, LXR activation in vivo induced autophagy suppression in glomeruli, leading to aggravated podocyte injury. In summary, our findings indicated that activation of LXRs induced autophagy suppression, which in turn contributed to the podocyte injury.

    Citation

    Ziyi Zhang, Shengjie Tang, Weiwei Gui, Xihua Lin, Fenping Zheng, Fang Wu, Hong Li. Liver X receptor activation induces podocyte injury via inhibiting autophagic activity. Journal of physiology and biochemistry. 2020 May;76(2):317-328

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32328877

    View Full Text